Xiaoxiong Xiao

452 total citations
17 papers, 335 citations indexed

About

Xiaoxiong Xiao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoxiong Xiao has authored 17 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoxiong Xiao's work include Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaoxiong Xiao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaoxiong Xiao collaborates with scholars based in China and United States. Xiaoxiong Xiao's co-authors include Tingwen Zhou, Nianguo Dong, Yongjun Wang, Qiao Zhang, Shichao Guo, Chao Guo, Ruimin Chang, Chunfang Zhang, Yang Gao and Xiaoyan Zhu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Xiaoxiong Xiao

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxiong Xiao China 9 193 173 61 43 37 17 335
András Försönits Hungary 4 135 0.7× 305 1.8× 21 0.3× 18 0.4× 49 1.3× 6 376
Cori N. Booker United States 6 108 0.6× 235 1.4× 25 0.4× 24 0.6× 7 0.2× 12 333
Bi‐Xin He China 8 89 0.5× 214 1.2× 67 1.1× 51 1.2× 40 1.1× 11 328
Bethany Claridge Australia 8 172 0.9× 383 2.2× 17 0.3× 12 0.3× 32 0.9× 13 441
Ning Geng China 13 111 0.6× 177 1.0× 20 0.3× 24 0.6× 11 0.3× 28 495
Wolfgang Peter Germany 10 37 0.2× 121 0.7× 11 0.2× 27 0.6× 19 0.5× 17 350
Antonio Echavez United States 5 207 1.1× 397 2.3× 31 0.5× 8 0.2× 15 0.4× 6 435
Matthew Kang New Zealand 6 152 0.8× 315 1.8× 25 0.4× 5 0.1× 14 0.4× 8 349
Anja A. Dünne Germany 12 52 0.3× 109 0.6× 64 1.0× 32 0.7× 15 0.4× 16 514

Countries citing papers authored by Xiaoxiong Xiao

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiong Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiong Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiong Xiao more than expected).

Fields of papers citing papers by Xiaoxiong Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiong Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiong Xiao. The network helps show where Xiaoxiong Xiao may publish in the future.

Co-authorship network of co-authors of Xiaoxiong Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiong Xiao. A scholar is included among the top collaborators of Xiaoxiong Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiong Xiao. Xiaoxiong Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Shenglan, et al.. (2024). Correlation between sarcopenia and esophageal cancer: a narrative review. World Journal of Surgical Oncology. 22(1). 27–27. 10 indexed citations
2.
Zhou, Wolong, Yuanda Cheng, Linfeng Li, et al.. (2023). Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma. Journal of Personalized Medicine. 13(3). 482–482. 1 indexed citations
3.
Zhang, Ziyu, Li Li, Yang Gao, et al.. (2023). Immune characteristics associated with lymph node metastasis in early-stage NSCLC. Cellular Oncology. 47(2). 447–461.
4.
Wang, Haiqin, et al.. (2023). Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance. Cellular Oncology. 47(1). 343–359. 10 indexed citations
5.
Xiao, Xiaoxiong, Min Chen, Yuchen Zhang, et al.. (2022). Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis. Journal of Nanobiotechnology. 20(1). 410–410. 32 indexed citations
6.
Liu, Kangcheng, et al.. (2022). Body shape and risk of glaucoma: A Mendelian randomization. Frontiers in Medicine. 9. 999974–999974. 10 indexed citations
7.
Ren, Jiannan, Naiwen Zhang, Xinlin Liu, et al.. (2022). CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer. Biochemical and Biophysical Research Communications. 613. 12–18. 7 indexed citations
8.
Feng, Songshan, Xisong Liang, Jing Li, et al.. (2022). Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM. Frontiers in Immunology. 13. 992855–992855. 7 indexed citations
9.
Xiao, Xiaoxiong, et al.. (2021). Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma. Molecular Carcinogenesis. 60(3). 179–187. 6 indexed citations
10.
Chang, Ruimin, Xiaoxiong Xiao, Yao Fu, et al.. (2021). ITGB1-DT Facilitates Lung Adenocarcinoma Progression via Forming a Positive Feedback Loop With ITGB1/Wnt/β-Catenin/MYC. Frontiers in Cell and Developmental Biology. 9. 631259–631259. 35 indexed citations
11.
Xiao, Xiaoxiong, Yue Li, Xuan Gao, et al.. (2021). The prevalence of HLA‐I LOH in Chinese pan‐cancer patients and genomic features of patients harboring HLA‐I LOH. Human Mutation. 42(10). 1254–1264. 6 indexed citations
12.
Wang, Yongjun, Xiaoxiong Xiao, Tingwen Zhou, Dong Han, & Nianguo Dong. (2019). Novel mechanisms for osteogenic differentiation of human aortic valve interstitial cells. Journal of Thoracic and Cardiovascular Surgery. 159(5). 1742–1753.e7. 13 indexed citations
13.
Xiao, Xiaoxiong, Ruimin Chang, & Yang Gao. (2019). <p>Clinical Outcomes And Cost-Effectiveness Of Different Staplers For Lung Lobectomy With Video-Assisted Thoracic Surgery</p>. Cancer Management and Research. Volume 11. 9599–9607. 2 indexed citations
14.
Li, Xizhe, Xiaoxiong Xiao, Ruimin Chang, & Chunfang Zhang. (2019). Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry. 121(1). 468–481. 19 indexed citations
15.
Xiao, Xiaoxiong, Tingwen Zhou, Shichao Guo, et al.. (2017). LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4. International Journal of Cardiology. 243. 404–412. 138 indexed citations
16.
Lai, Xuxin, Jing Li, Xiaoxiong Xiao, et al.. (2012). Specific IgG4 Production during House Dust Mite Immunotherapy among Age, Gender and Allergic Disease Populations. International Archives of Allergy and Immunology. 160(1). 37–46. 37 indexed citations
17.
Xiao, Xiaoxiong. (2007). Study of nighttime sleep in children aged 6 to 12 years in Zhongshan city. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026